Disc Medicine, Inc. Common Stock (IRON) Stock Price

IRONStock
$82.41+34.12%52W
Market Cap$3.16B
P/E
PEG Ratio
Div yield
Beta0.90

IRON Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)14.28%
Price vs S&P 500 (4W)5.37%
VGM Score65.06

IRON Earnings Surprise History

Q2 25-1.58est. -1.14
Q3 25-1.77est. -1.46
Q4 25-1.62est. -1.70
Q1 26-1.65est. -1.73
Q2 26-1.54est. -1.77

IRON Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.32
4.32
4.32
4.32

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
IRONDisc Medicine, Inc. Common Stock
B$82.41
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Disc Medicine, Inc. Common Stock

Disc Medicine is a clinical-stage biopharmaceutical company developing treatments for hematologic disorders through modulation of heme biosynthesis and iron homeostasis. The company's pipeline includes bitopertin for erythropoietic porphyrias, DISC-0974 for anemia in myelofibrosis and chronic kidney disease, and DISC-3405 for polycythemia vera. These programs target conditions with significant unmet medical needs and substantial market opportunities.